|
Q4 2023
|
9 |
648,896 |
IRWD, BIIB, INVA, GILD
|
13F-HR
|
2/14/2024 |
000089914024000250 |
|
Q3 2023
|
11 |
742,379 |
ALKS, BIIB, IRWD, INVA
|
13F-HR
|
11/14/2023 |
000089914023001108 |
|
Q2 2023
|
11 |
1,004,526 |
ALKS, BIIB, IRWD, INVA
|
13F-HR
|
8/14/2023 |
000089914023000886 |
|
Q1 2023
|
11 |
781,897 |
ALKS, BIIB, IRWD, INVA
|
13F-HR
|
5/15/2023 |
000089914023000651 |
|
Q4 2022
|
11 |
840,211 |
ALKS, IRWD, BIIB, GILD
|
13F-HR
|
2/14/2023 |
000089914023000407 |
|
Q3 2022
|
11 |
884,819 |
ALKS, BIIB, IRWD, GILD
|
13F-HR
|
11/14/2022 |
000156761922020094 |
|
Q2 2022
|
11 |
993,488 |
ALKS, IRWD, BIIB, INVA
|
13F-HR
|
8/15/2022 |
000156761922016259 |
|
Q1 2022
|
11 |
1,057,966 |
ALKS, IRWD, BIIB, INVA
|
13F-HR
|
5/16/2022 |
000156761922011017 |
|
Q4 2021
|
11 |
1,155,293 |
ALKS, GILD, IRWD, BIIB
|
13F-HR
|
2/14/2022 |
000156761922004425 |
|
Q3 2021
|
10 |
1,273,975 |
ALKS, IRWD, GILD, BIIB
|
13F-HR
|
11/15/2021 |
000156761921020494 |
|
Q2 2021
|
14 |
1,257,696 |
ALKS, BIIB, IRWD, GILD
|
13F-HR
|
8/16/2021 |
000156761921015920 |
|
Q1 2021
|
14 |
1,043,262 |
IRWD, BIIB, GILD, ALKS
|
13F-HR
|
5/17/2021 |
000156761921010558 |
|
Q4 2020
|
12 |
979,780 |
IRWD, ALKS, BIIB, JAZZ
|
13F-HR
|
2/16/2021 |
000156761921003998 |
|
Q3 2020
|
11 |
849,434 |
BIIB, JAZZ, ALKS, IRWD
|
13F-HR
|
11/16/2020 |
000156761920019849 |
|
Q2 2020
|
12 |
898,918 |
BIIB, ALKS, IRWD, JAZZ
|
13F-HR
|
8/14/2020 |
000156761920015463 |
|
Q1 2020
|
12 |
783,828 |
BIIB, IRWD, ALKS, AGN
|
13F-HR
|
5/15/2020 |
000156761920010481 |
|
Q4 2019
|
13 |
1,204,783 |
MDCO, BIIB, IRWD, ICPT
|
13F-HR
|
2/14/2020 |
000156761920003999 |
|
Q3 2019
|
12 |
797,914 |
MDCO, AGN, BIIB, IRWD
|
13F-HR
|
11/14/2019 |
000156761919021592 |
|
Q2 2019
|
13 |
802,161 |
AGN, MDCO, BIIB, IRWD
|
13F-HR
|
8/14/2019 |
000156761919017020 |
|
Q1 2019
|
11 |
664,251 |
AGN, BIIB, IRWD, MDCO
|
13F-HR
|
5/15/2019 |
000156761919011163 |
|
Q4 2018
|
10 |
451,249 |
BIIB, INVA, AGN, IRWD
|
13F-HR
|
2/14/2019 |
000156761919004398 |
|
Q3 2018
|
9 |
453,306 |
BIIB, INVA, AGN, IRWD
|
13F-HR
|
11/14/2018 |
000156761918006318 |
|
Q2 2018
|
10 |
498,793 |
BIIB, MDCO, IRWD, INVA
|
13F-HR
|
8/14/2018 |
000156761918001107 |
|
Q1 2018
|
11 |
432,144 |
BIIB, MDCO, INVA, AGN
|
13F-HR
|
5/15/2018 |
000114036118023974 |
|
Q4 2017
|
11 |
390,650 |
BIIB, BIVV, MDCO, INVA
|
RESTATEMENT
|
2/23/2018 |
000114036118009863 |
|
Q3 2017
|
9 |
323,993 |
BIIB, BIOVERATIV INC, MDCO, INVA
|
13F-HR
|
11/14/2017 |
000114036117042883 |
|
Q2 2017
|
8 |
299,557 |
BIIB, BIOVERATIV INC, MDCO, INVA
|
13F-HR
|
8/14/2017 |
000114036117032001 |
|
Q1 2017
|
11 |
253,055 |
MDCO, BIIB, INVA, NOVELION THERAPEUTICS INC
|
13F-HR
|
5/15/2017 |
000114036117020718 |
|
Q4 2016
|
11 |
363,082 |
ARIA, BIIB, MDCO, INVA
|
13F-HR
|
2/14/2017 |
000114036117007278 |
|
Q3 2016
|
14 |
434,231 |
ARIA, BIIB, MDCO, ARRY
|
13F-HR
|
11/14/2016 |
000114036116086479 |
|
Q2 2016
|
15 |
352,312 |
ARIA, BIIB, MDCO, ITCI
|
13F-HR
|
8/15/2016 |
000114036116076729 |
|
Q1 2016
|
16 |
453,821 |
ABBV, ARIA, BIIB, MDCO
|
13F-HR
|
5/16/2016 |
000114036116065701 |
|
Q4 2015
|
17 |
514,358 |
BIIB, ABBV, ARIA, MDCO
|
13F-HR
|
2/16/2016 |
000114036116053204 |
|
Q3 2015
|
18 |
404,891 |
ABBV, ARIA, MDCO, DGX
|
13F-HR
|
11/16/2015 |
000114036115041780 |
|
Q2 2015
|
16 |
434,562 |
ARIA, ABBV, DGX, MDCO
|
13F-HR
|
8/14/2015 |
000114036115032371 |
|
Q1 2015
|
17 |
474,075 |
ARIA, ABBV, DGX, AMGN
|
13F-HR
|
5/15/2015 |
000114036115019796 |
|
Q4 2014
|
16 |
282,531 |
ARIA, DGX, AMGN, MRK
|
13F-HR
|
2/17/2015 |
000114036115006874 |
|
Q3 2014
|
14 |
258,936 |
ARIA, DGX, BRLI, A
|
13F-HR
|
11/14/2014 |
000114036114041694 |
|
Q2 2014
|
15 |
294,075 |
ARIA, IDIX, DGX, BRLI
|
13F-HR
|
8/14/2014 |
000114036114032743 |
|
Q1 2014
|
15 |
290,423 |
ARIA, DGX, BRLI, IDIX
|
13F-HR
|
5/15/2014 |
000114036114021259 |
|
Q4 2013
|
12 |
267,017 |
ARIA, DGX, IDIX, VVUSQ
|
13F-HR
|
2/14/2014 |
000114036114007193 |